Sign in

CIK 0001819790

  • Large accelerated filer

Tarsus Pharmaceuticals, Inc.

Sign in to watch
Ticker
TARS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
814717861
Phone
+1 949-409-9820
Business address
15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,995,859
in 7 filings, $6.0M under 10b5-1 plans

Net −$5,995,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-03-15 Azamian Bobak R. President/CEO and Board Chair Exercise or conversion +28,274 36,871
2024-03-15 Azamian Bobak R. President/CEO and Board Chair Exercise or conversion · Restricted Stock Units −11,299 22,599
2024-03-15 Azamian Bobak R. President/CEO and Board Chair Exercise or conversion · Restricted Stock Units −16,975 50,925
2024-03-15 Whitfield Dianne C. Chief Human Resources Officer Exercise or conversion +11,711 38,495
2024-03-15 Whitfield Dianne C. Chief Human Resources Officer Exercise or conversion · Restricted Stock Units −4,463 8,925
2024-03-15 Whitfield Dianne C. Chief Human Resources Officer Exercise or conversion · Restricted Stock Units −7,248 21,745
2024-03-15 Neervannan Seshadri Chief Operating Officer Exercise or conversion +13,245 69,646
2024-03-15 Neervannan Seshadri Chief Operating Officer Exercise or conversion · Restricted Stock Units −5,097 10,194
2024-03-15 Neervannan Seshadri Chief Operating Officer Exercise or conversion · Restricted Stock Units −8,148 24,444
2024-03-07 Wahl Bryan General Counsel Grant or award · Stock Option (right to buy) +42,500 42,500
2024-03-07 Wahl Bryan General Counsel Grant or award · Restricted Stock Units +28,702 28,702
2024-03-07 Azamian Bobak R. President/CEO and Board Chair Grant or award · Stock Option (right to buy) +136,947 136,947
2024-03-07 Azamian Bobak R. President/CEO and Board Chair Grant or award · Restricted Stock Units +92,485 92,485
2024-03-07 Mottiwala Aziz Chief Commercial Officer Grant or award · Stock Option (right to buy) +47,500 47,500
2024-03-07 Mottiwala Aziz Chief Commercial Officer Grant or award · Restricted Stock Units +32,079 32,079
2024-03-07 Whitfield Dianne C. Chief Human Resources Officer Grant or award · Stock Option (right to buy) +42,500 42,500
2024-03-07 Whitfield Dianne C. Chief Human Resources Officer Grant or award · Restricted Stock Units +28,702 28,702
2024-03-07 Farrow Jeffrey S Grant or award · Stock Option (right to buy) +47,500 47,500
2024-03-07 Farrow Jeffrey S Grant or award · Restricted Stock Units +32,079 32,079
2024-03-07 Neervannan Seshadri Chief Operating Officer Grant or award · Stock Option (right to buy) +47,500 47,500

Page 16 of 24 · 469 trades